Human Anti-Codrituzumab (GPC3)
Codrituzumab is under investigation in clinical trial NCT01507168 (A Study of RO5137382 (GC33) in patients with advanced or metastatic hepatocellular carcinoma).
Applications
Suitable for use in ELISA and SDS-PAGE. Other applications not tested.
Recommended Dilution
Optimal dilutions to be determined by the researcher.
Storage and Stability
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Immunogen
Recombinant protein corresponding to humanized GPC3 [Homo sapiens], expressed in CHO cells.
Form
Supplied as a liquid in PBS, pH 7.5.
Specificity
Recognizes Codrituzumab (GPC3).
